(Q42168697)

17 October 2017

In vitro induction of fetal hemoglobin in human erythroid progenitor cells (English)

1 reference

17 October 2017

Janie A Ho

1

1 reference

17 October 2017

Chrisley V Pickens

2

1 reference

17 October 2017

Michael P Gamcsik

3

1 reference

17 October 2017

O Michael Colvin

4

1 reference

17 October 2017

Russell E Ware

5

1 reference

17 October 2017

1 July 2003

1 reference

17 October 2017

Experimental Hematology

1 reference

17 October 2017

31

1 reference

17 October 2017

586-591

1 reference

17 October 2017

7

1 reference

Pain in sickle cell disease. Rates and risk factors

17 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

ß s -Gene-Cluster Haplotypes in Sickle Cell Anemia: Clinical and Hematologic Features

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Hemoglobin sickle-Lepore: report of two siblings and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Mortality in sickle cell disease. Life expectancy and risk factors for early death.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

The relationship between fetal hemoglobin and disease severity in children with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Treatment of sickle cell anemia with hydroxyurea and erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Arabinosylcytosine Induces Fetal Hemoglobin in Baboons by Perturbing Erythroid Cell Differentiation Kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Hb F production in stressed erythropoiesis: observations and kinetic models.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

BFU-E colony growth in response to hydroxyurea: correlation between in vitro and in vivo fetal hemoglobin induction

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Enhancement of hemoglobin and F-cell production by targeting growth inhibition and differentiation of K562 cells with ribonucleotide reductase inhibitors (didox and trimidox) in combination with streptozotocin

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Hydroxyurea: new insights on an old drug

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

In vivo production of nitric oxide in rats after administration of hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Hydroxyurea reacts with heme proteins to generate nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

EPR stopped-flow studies of the reaction of the tyrosyl radical of protein R2 from ribonucleotide reductase with hydroxyurea

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Inhibition of tumor cell ribonucleotide reductase by macrophage-derived nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Nitric oxide and the regulation of gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Relationship of burst-forming-unit-erythroid progenitors and their DNA-synthesis stage to fetal hemoglobin levels in hydroxyurea-treated patients with sickle cell anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

Predictors of fetal hemoglobin response in children with sickle cell anemia receiving hydroxyurea therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900086-9

7 January 2021

10.1016/S0301-472X(03)00086-9

Identifiers

DOI

1 reference

17 October 2017

1 reference